Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma.

biomarker kidney lamin-B1 renal cell carcinoma senescence

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 13 11 2018
accepted: 03 04 2019
entrez: 13 8 2019
pubmed: 14 8 2019
medline: 14 8 2019
Statut: ppublish

Résumé

Clear-cell renal cell carcinoma (ccRCC) is a von-Hippel-Lindau gene (

Identifiants

pubmed: 31402955
doi: 10.3892/ol.2019.10593
pii: OL-0-0-10593
pmc: PMC6676677
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2654-2660

Références

Gut. 1999 Nov;45(5):723-9
pubmed: 10517909
J Urol. 2004 Sep;172(3):867-70
pubmed: 15310985
Nature. 2005 Aug 4;436(7051):720-4
pubmed: 16079850
Nature. 2005 Aug 4;436(7051):725-30
pubmed: 16079851
Oncol Rep. 2006 Mar;15(3):609-13
pubmed: 16465420
Nat Genet. 2006 Oct;38(10):1114-23
pubmed: 16951681
Cancer Cell. 2006 Dec;10(6):459-72
pubmed: 17157787
Cancer Res. 2007 Apr 1;67(7):3171-6
pubmed: 17409424
Cancer Cell. 2008 Jan;13(1):11-22
pubmed: 18167336
Nat Cell Biol. 2008 Mar;10(3):361-9
pubmed: 18297059
Nat Rev Cancer. 2008 Nov;8(11):865-73
pubmed: 18923434
Clin Cancer Res. 2009 Jan 15;15(2):650-9
pubmed: 19147771
J Proteome Res. 2010 Jan;9(1):70-8
pubmed: 19522540
Mol Cell Biol. 2010 Oct;30(19):4595-603
pubmed: 20679489
J Natl Cancer Inst. 2010 Oct 20;102(20):1536-46
pubmed: 20858887
Genes Dev. 2010 Nov 15;24(22):2463-79
pubmed: 21078816
Genes Dev. 2011 Dec 15;25(24):2579-93
pubmed: 22155925
Trends Cell Biol. 2012 Apr;22(4):211-9
pubmed: 22245068
Mol Cancer Res. 2012 Jul;10(7):859-80
pubmed: 22638109
Mol Neurobiol. 2013 Feb;47(1):290-301
pubmed: 23065386
PLoS One. 2012;7(12):e51862
pubmed: 23251644
Cancer Sci. 2013 Aug;104(8):1052-61
pubmed: 23578198
Clin Cancer Res. 2013 Sep 1;19(17):4651-61
pubmed: 23857605
Genes Dev. 2013 Aug 15;27(16):1787-99
pubmed: 23934658
Oncol Rep. 2013 Nov;30(5):2245-53
pubmed: 23982490
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Sci Rep. 2016 Aug 22;6:31758
pubmed: 27545311
Mol Cancer. 2016 Dec 19;15(1):83
pubmed: 27993170
N Engl J Med. 2017 Jan 26;376(4):354-366
pubmed: 28121507
CA Cancer J Clin. 2017 Nov;67(6):507-524
pubmed: 28961310
Oncotarget. 2017 Sep 11;8(45):78545-78555
pubmed: 29108248
Int J Oncol. 2018 Jan;52(1):89-102
pubmed: 29115590
Front Pharmacol. 2018 Apr 16;9:163
pubmed: 29713275
Am J Pathol. 1993 Jul;143(1):211-20
pubmed: 8391215
Cell. 1997 Mar 7;88(5):593-602
pubmed: 9054499
Biometrics. 1997 Sep;53(3):1151-6
pubmed: 9333345

Auteurs

Melissa Marie Radspieler (MM)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.

Mario Schindeldecker (M)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.
Tissue Biobank, University Medical Center Mainz, D-55131 Mainz, Germany.

Philipp Stenzel (P)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.

Sebastian Försch (S)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.

Katrin E Tagscherer (KE)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.

Esther Herpel (E)

Institute of Pathology, University Hospital Heidelberg, D-69120 Heidelberg, Germany.
Tissue Bank of The National Center for Tumor Diseases, University Hospital Heidelberg, D-69120 Heidelberg, Germany.

Markus Hohenfellner (M)

Department of Urology, University Hospital Heidelberg, D-69120 Heidelberg, Germany.

Gencay Hatiboglu (G)

Department of Urology, University Hospital Heidelberg, D-69120 Heidelberg, Germany.

Wilfried Roth (W)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.

Stephan Macher-Goeppinger (S)

Institute of Pathology, University Medical Center Mainz, D-55131 Mainz, Germany.
Tissue Biobank, University Medical Center Mainz, D-55131 Mainz, Germany.

Classifications MeSH